| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |